Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacodynamic Models: Overview

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Redox-activated cholesterol-dependent cytolysin enables cytosolic release of liposomal cargo.

International journal of biological macromolecules·2026

Same author

Chlorinated Bis-phenolic Disinfectants Inhibit Human and Rat Aromatase.

Chemico-biological interactions·2026

Same author

Benzalkonium chloride disrupts human placental progesterone synthesis via locking NAD<sup>+</sup> pocket in 3β-Hydroxysteroid dehydrogenase 1 and rat homolog: docking evidence and 3D-QSAR, and experiment risk assessment.

Bioorganic chemistry·2026

Same author

Publisher Correction: Lung and liver editing by lipid nanoparticle delivery of a stable CRISPR-Cas9 ribonucleoprotein.

Nature biotechnology·2026

Same author

Targeting Cancer-Specific Mutations with RNA-Triggered Chromatin Shredding.

Nature·2026

Same author

Evolutionary acquisition of an interaction between conserved proteins drives plant-specific cell cycle progression.

Nature communications·2026

Search research articles

Related Experiment Video

Updated: Jun 25, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

Dimensionless parameter predicts bacterial prodrug success.

Brandon Alexander Holt¹, McKenzie Tuttle¹, Yilin Xu¹

¹Wallace H. Coulter Department of Biomedical Engineering, Georgia Tech College of Engineering and Emory School of Medicine, Atlanta, GA, USA.

Molecular Systems Biology

|January 10, 2022

Summary

This summary is machine-generated.

Prodrugs can fail when bacteria replicate faster than the drug activates. A new Bacterial Advantage Heuristic (BAH) predicts and helps prevent this antibiotic resistance escape.

Keywords:

antibiotic failure bacteria enzymes minimum inhibitory concentration prodrugs

More Related Videos

Design and Use of a Low Cost, Automated Morbidostat for Adaptive Evolution of Bacteria Under Antibiotic Drug Selection

Design and Use of a Low Cost, Automated Morbidostat for Adaptive Evolution of Bacteria Under Antibiotic Drug Selection

Published on: September 27, 2016

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

Published on: November 16, 2016

Related Experiment Videos

Last Updated: Jun 25, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

Design and Use of a Low Cost, Automated Morbidostat for Adaptive Evolution of Bacteria Under Antibiotic Drug Selection

Design and Use of a Low Cost, Automated Morbidostat for Adaptive Evolution of Bacteria Under Antibiotic Drug Selection

Published on: September 27, 2016

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

Published on: November 16, 2016

Area of Science:

Microbiology and Infectious Diseases
Pharmacology and Pharmaceutical Sciences
Mathematical Biology

Background:

Antibiotic failure due to multidrug-resistant bacteria is a growing global health threat.
Prodrugs, activated after administration, are a promising therapeutic class but their failure mechanisms remain understudied.
Pathogen-specific prodrug activation pathways may be vulnerable to competing rates of activation and bacterial replication.

Purpose of the Study:

To hypothesize and mathematically model conditions leading to prodrug treatment failure.
To derive a predictive parameter for prodrug escape versus successful treatment.
To experimentally validate the model and explore strategies for rescuing failing prodrugs.

Main Methods:

Construction of a mathematical model for prodrug kinetics.
Derivation of the dimensionless Bacterial Advantage Heuristic (BAH) parameter.
In vitro validation using two distinct bacteria-prodrug competition models (antimicrobial peptide and trimethoprim conjugate).

Main Results:

The BAH parameter accurately predicts the transition between prodrug escape and successful treatment.
Prodrug failure was observed experimentally at BAH values exceeding a critical threshold.
Strategies including substrate design and nutrient control were shown to decrease BAH and rescue failing prodrugs.

Conclusions:

The BAH provides a predictive framework for understanding and preventing prodrug failure.
Prodrug activation rate relative to bacterial replication rate is critical for therapeutic success.
Dimensionless parameters like BAH can guide the rational design and administration of prodrug therapeutics.